期刊文献+

多普勒超声心动图检测慢性心力衰竭患者心肌生物能量消耗水平的变化及临床意义 被引量:22

Value of Doppler echocardiography derived myocardial energy expenditure measurements in chronic heart failure patients
原文传递
导出
摘要 目的分析慢性心力衰竭(心衰)患者的多普勒超声指标心肌生物能量消耗(MEE)与左心室结构指标及其收缩、舒张、整体功能指标及心衰严重程度(NYHA心功能分级)、C反应蛋白(CRP)、N末端B型利钠肽原(NT—proBNP)之间的关系,探讨MEE用于评估慢性心衰心功能状况的临床价值。方法选择慢性心衰住院患者99例,据左室射血分数(LVEF)值分为LVEF正常的心衰(HFNEF)组37例,INEF降低的心衰(HFREF)组62例(其中LVEF〉35%、〈50%及≤35%分别为30例及32例);据NYHA心功能分级分为Ⅱ级(26例)、Ⅲ级(42例)、Ⅳ级(31例);对照组30例。采用多普勒超声心动图检测并计算MEE及常规结构指标,左心室收缩(LVEF、LVFS)、舒张(E/A、EDT、IVRT)及整体功能指标(Tei指数),并测定各组血清CRP、血浆NT—proBNP水平,分析各组间各参数的差异,探讨MEE与上述指标问的相关性。结果HFNEF组患者MEE水平与对照组差异无统计学意义(P〉0.05),HFREF组患者MEE水平较对照组明显增加(P〈0.01);慢性心衰组MEE随LVEF的降低及NYHA心功能分级级别的升高而显著增加(P〈0.05);双变量相关分析显示,MEE与心室结构及收缩、舒张、整体功能指标、NYHA心功能分级及血清CRP、血浆NT—proBNP水平之间均具有相关性,其中关系最密切的是左心室收缩功能指标,即MEE与LVEF、LVFS均呈明显负相关[分别为r=-0.540、P〈0.01,r=-0.454、P〈0.01]。结论随左心室收缩功能障碍及心衰程度的加重,慢性心衰患者的MEE水平逐步升高,MEE与现有的心功能评价指标(如LVEF值、NYHA分级、NT.proBNP等)均呈明显相关,特别与左心室收缩功能指标关系密切。MEE可从心肌生物能量学角度有效评定慢性心衰患者的心功能状况。 Objective To evaluate the relationship between myocardial energy expenditure (MEE) level and cardiac function in chronic heart failure (CHF) patients. Methods A total of 99 CHF patients were divided into 3 groups according to the LVEF ( HFNEF≥50%, n =37; HFREF1 35.1% -49. 9%, n=30; HFREF2 ≤35% , n=32) or the New York Heart Association (NYHA Ⅱ , n =26; Ⅲ, n =42; Ⅳ, n = 31 ) criteria. Thirty patients with cardiovascular disease and without CHF served as controls. Routine examinations including serum CRP (ELISA) and plasma NT-proBNP (chemiluminescence sandwich ELISA) were made on the next morning after admission; echocardiography was performed on the third day after admission. LVMW, LVMWI, RWT, LVIDd, LA, LV, LVEF, LVFS, E/A, EDT, IVRT, Tei index and MEE were measured or calculated. Results MEE was significantly higher in HFREF patients than in controls ( P 〈 O. 01 ) and similar between HFNEF patients and controls ( P 〉 0. 05 ). MEE increased in proportion to decrease of LVEF and increase of NYHA grades in CHF patients ( all P 〈 0. 05 ) . Bivariate analysis confirmed that MEE was significant correlated with LVMW, LVMWI, RWT, LVIDd, LA, LV, LVEF (r = - O. 540, P 〈 0. 01 ), LVFS (r = - 0. 454, P 〈 0. 01 ), E/A, EDT, IVRT, Tei index, NYHA grades, CRP and NT-proBNP. Conclusion MEE derived from standard echocardiographic measurements is an effective indicator for myocardial bioenergetics and significantly correlated with cardiac function in CHF patients, especially in CHF patients with reduced LVEF.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2010年第3期209-214,共6页 Chinese Journal of Cardiology
关键词 心力衰竭 充血性 超声心动描记术 多普勒 心肌能量消耗 Heart failure, congestive Echocardiography, Doppler Myocardial energy expenditure
  • 相关文献

参考文献20

  • 1Ickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29: 2388-2442.
  • 2Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypearophy: comparison to necropsy findings. Am J Cardiol, 1986, 57: 450-458.
  • 3Tel C, Dujacdin KS, Hodgc DO, et al. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol, 1996, 28: 558-654.
  • 4Palmieri V, Bella JN, Arnett DK, et al. Associations of aortic and mitral regurgitation with body composition and myocardial energy expenditure in adults with hypertension: the hypertension genetic epidemiology network study. Am Heart J, 2003, 145: 1071- 1077.
  • 5Shimizu G, hirota Y, Kita Y, et al. Left ventricular midwall mechanics in systemic arterial hypertension: myocardial function is depressed in pressure-overload hypertrophy. Circulation, 1991, 83 : 1676-1684.
  • 6De Simone G, Devereux RB, Roman M J, et al. Assessment of left ventricular function by the midwall fractional shortening/end- systolic stress relation in human hypertension. J Am Coil Cardiol, 1994, 23: 1444-1451.
  • 7Devereux RB, Roman M J, Paranicas M, et al. Relations of Doppler stroke volume and its components to left ventricular stroke volume in normotensive and hypertensive American Indians: the Strong Heart Study. Am J Hypertens, 1997, 10: 619-628.
  • 8Tian R. Understanding the metabolic phenotype of heart disease. Heart Metabolism, 2006, 32: 5-8.
  • 9Stefan Neubauer. The failing heart - an engine out of fuel. N Engl J Med, 2007, 356: 1140-1151.
  • 10Neubauer S, Krahe T, Schindler R, et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: altered cardiac high-energy phosphate metabolism in heart failure. Circulation, 1992, 86: 1810-1818.

二级参考文献20

  • 1耿庆信,朱梅,张兴华,朱兴雷,刘传玺.Tei指数检测对心肌梗死患者择期经皮冠状动脉介入治疗后左心功能评价[J].中国中西医结合影像学杂志,2004,2(2):88-90. 被引量:6
  • 2章鸣,周启昌,彭清海,范萍.组织多普勒成像测量正常成人右室Tei指数的研究[J].中国医学影像技术,2004,20(10):1558-1560. 被引量:42
  • 3Edwards BS, Zimmermann RS, Burnett JC Jr. Atrial natriuretic factor: physiologic action and implications in congestive heart failure.Cardiovasc Drugs Ther,1987, 1 : 89-100.
  • 4Hunt PJ, Yandle TG, Nicholls MG, et al. The amino-terminal portion of pro-brain natriuretic peptide (pro-BNP) circulates in human plasma. Biochem Biophysl Res Commun, 1995, 214:1175-1183.
  • 5Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive aminoterminal pro-brain natriuretie peptide (NT-PROBNP) : a new marker of cardiac impairment. Clin Endocrinol, 1997, 47 : 287-296.
  • 6Sahn D J, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation of M-mode echecardiography: results of survey of echecardiography measurements. Circulation, 1978, 58 : 1072-1083.
  • 7Vogeser M, Jacob K. B-type natriuretic peptide (BNP)--validation of an immediate response assay. Clin Lab, 2001, 47:29-33.
  • 8Sayama H, Nakamura Y, Saito N, et al. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron Artery Dis. 1999. 10:537-540.
  • 9Maeda K, Tsutamoto T, Wada A, et al. Plasma Brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure with symptomatic left ventricular dysfunction. Am. Heart J,1998, 135:825-832.
  • 10Hall C, Kjekshus J, Eneroch P, et al. The plasma concentration of N-terminal proatrial natriuretie factor ANF (1-98) is related to prognosis in severe heart failure. Clin Cardiol, 1994, 17:191-195.

共引文献73

同被引文献196

引证文献22

二级引证文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部